May 5, 2020 - Benchling Launches Integrated Analytics Solution to Accelerate Life Science R&D
Benchling, the leading life sciences R&D cloud, today announced the launch of Benchling Insights, a new solution that gives life sciences companies the ability to query, visualize and collaborate around high quality, structured data that resides on the platform. Benchling Insights delivers a 360-degree view of scientific programs and operations to drive faster, more informed decision-making.April 28, 2020 - Proscia® Offers Concentriq® Digital Pathology Software for Remote Use in Clinical Practice in the United States
Proscia® has made available the Concentriq Dx® digital pathology software for use in reviewing and reporting of digital pathology slides in the United States. Concentriq Dx, which is CE-marked for use in primary diagnosis in Europe, will support the need for remote pathology in the United States brought about by the COVID-19 pandemic.April 21, 2020 - Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing
Eurofins Genomics U.S. announces that, together with its subsidiary BlueHeron Biotechnology, it has launched a series of SARS-CoV-2 plasmid DNA controls that can be used to verify the presence of the SARS-CoV-2 virus. They are intended to be used for both research and development and IVD diagnostic applications.April 21, 2020 - Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
Illumina, Inc. announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to critical public databases. Illumina is making the toolkit available at no cost to the global research community in support of efforts to combat the pandemic.April 21, 2020 - Autoscribe Informatics Announces LIMS Distributor in West Africa
Autoscribe Informatics is delighted to announce that it has appointed Promatics Technologies Nigeria as our distributor in Nigeria to sell, configure and support the Matrix family of Laboratory Information Management System (LIMS) products. Based in Abuja, Nigeria, Promatics Technologies provide a range of technology services and consulting solutions, including healthcare and clinical systems, to clients across the region.April 14, 2020 - Taking on the Pandemic: Transforming a Clinical Lab Into a COVID-19 Ready Lab
L7 Informatics Inc., and Contamination Source Identification (CSI) deploy 'ready to go' COVID-19 workflows based on the CDC testing protocol for testing laboratories supporting coronavirus patient screening.April 14, 2020 - Studying #COVID19 around the world using the Hidex Sense microplate reader
Hidex Sense microplate reader used to research mechanisms, diagnostics, and therapeutic targets of SARS-CoV-2. As the global COVID-19 (also known as SARS-CoV-2) crisis continues to unfold, it’s important to recognise the scientists behind the vital studies investigating the virus. The current pressing task of epidemiologists and virologists around the world is studying the mechanisms and transmission of SARS-CoV-2, to better understand the virus whilst revealing therapeutic targets.April 14, 2020 - Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat
Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat. The ANPC team has launched a major research and diagnostics project to better understand and predict variation in COVID-19 severity and determine the complex genetic, environmental and lifestyle interactions that influence its pathogenicity in individuals. Later they will engage with clinical trials of novel antiviral agents and when available vaccines in order to predict responder/non-responder outcomes.April 14, 2020 - Visiopharm and Proscia® Partner to Deliver AI-Enabled Solutions that Advance Precision Medicine
Visiopharm, the leader in precision pathology software, and Proscia, a leader in digital pathology image and workflow management, have entered into a multi-year, strategic partnership to deliver deeply integrated AI-enabled solutions that drive breakthroughs in translational research and advance precision medicine.April 7, 2020 - Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)
hermo Fisher Scientific announces the availability of the Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control, its latest quality control product to monitor and validate COVID-19 molecular diagnostic tests.April 7, 2020 - Wiley Acquires Bio-Rad’s Informatics Spectroscopy Software and Spectral Databases
John Wiley and Sons Inc. today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases.April 7, 2020 - EccoVia Solutions COVID-19 Screening Tool
EccoVia Solutions, a leading provider of health and human services cloud-based solutions, announces today that they have successfully completed the implementation of a COVID-19 screening tool in the company’s signature software platform, ClientTrack©.April 7, 2020 - Innovative Cloud-based Tech to Rapidly Increase COVID-19 Testing Capacity Across The US
OnGen, an advanced laboratory information management system (LIMS) is helping laboratories to increase their testing capacity and provide testing results at an unprecedented rate during the COVID-19 outbreak.March 31, 2020 - LabLynx Joins the COVID-19 Fight by Introducing New CovidLiMS
ATLANTA – LabLynx, Inc., long-time leader in enterprise-level cloud-hosted LIMS/LIS, today announced it has developed the world’s first LIMS (Laboratory Information Management System) dedicated specifically to COVID-19 diagnostic testing. Called "CovidLIMS”, its main features include, crucially, swift setup-to-live time: 2-5 days, including training, according to LabLynx President John H. Jones.
